BACKGROUND: Hemorrhagic cystitis (HC) results in significant morbidity among hematopoietic stem cell transplant (HSCT) recipients. Several potential causes for HC have been postulated, including viral infection, but definitive evidence is lacking, particularly in pediatric HSCT patients. METHODS: Ninety pediatric HSCT recipients were prospectively tested on a weekly basis for adenovirus (ADV) and BK virus (BKV) by quantitative real-time polymerase chain reaction in blood and urine samples. Results were correlated with the occurrence of grade II-IV HC. The odds ratio (OR) of HC (95% confidence interval) for BKV ≥1 × 10(9) copies/mL of urine was 7.39 (1.52, 35.99), with a P-value of 0.013. Those with acute graft-versus-host disease (aGVHD) also had higher odds of developing HC, with an OR of 5.34. Given a 20% prevalence rate of HC, positive and negative predictive values of 29% and 95% were seen with a cutoff of 10(9) copies/mL. RESULTS: BK viremia did not reach significance as a risk factor for development of HC (P = 0.06). Only 8 patients showed ADV viruria and 7 showed ADV viremia; all had low viral loads and 4 had no evidence of HC. CONCLUSION: HC in pediatric HSCT is correlated most strongly to elevated urinary viral load of BKV and to aGVHD, but less strongly to BK viremia.
BACKGROUND:Hemorrhagic cystitis (HC) results in significant morbidity among hematopoietic stem cell transplant (HSCT) recipients. Several potential causes for HC have been postulated, including viral infection, but definitive evidence is lacking, particularly in pediatric HSCT patients. METHODS: Ninety pediatric HSCT recipients were prospectively tested on a weekly basis for adenovirus (ADV) and BK virus (BKV) by quantitative real-time polymerase chain reaction in blood and urine samples. Results were correlated with the occurrence of grade II-IV HC. The odds ratio (OR) of HC (95% confidence interval) for BKV ≥1 × 10(9) copies/mL of urine was 7.39 (1.52, 35.99), with a P-value of 0.013. Those with acute graft-versus-host disease (aGVHD) also had higher odds of developing HC, with an OR of 5.34. Given a 20% prevalence rate of HC, positive and negative predictive values of 29% and 95% were seen with a cutoff of 10(9) copies/mL. RESULTS:BK viremia did not reach significance as a risk factor for development of HC (P = 0.06). Only 8 patients showed ADV viruria and 7 showed ADV viremia; all had low viral loads and 4 had no evidence of HC. CONCLUSION: HC in pediatric HSCT is correlated most strongly to elevated urinary viral load of BKV and to aGVHD, but less strongly to BK viremia.
Authors: S Cesaro; C Facchin; G Tridello; C Messina; E Calore; M A Biasolo; M Pillon; S Varotto; A Brugiolo; C Mengoli; G Palù Journal: Bone Marrow Transplant Date: 2007-11-05 Impact factor: 5.483
Authors: R T Hayden; X Yan; M T Wick; A B Rodriguez; X Xiong; C C Ginocchio; M J Mitchell; A M Caliendo Journal: J Clin Microbiol Date: 2011-11-23 Impact factor: 5.948
Authors: Helen B Viscount; Albert J Eid; Mark J Espy; Matthew D Griffin; Kristine M Thomsen; William S Harmsen; Raymund R Razonable; Thomas F Smith Journal: Transplantation Date: 2007-08-15 Impact factor: 4.939
Authors: Benjamin L Laskin; Michelle R Denburg; Susan L Furth; Taylor Moatz; Michelle Altrich; Steve Kleiboeker; Carolyn Lutzko; Xiang Zhu; Jason T Blackard; Sonata Jodele; Adam Lane; Gregory Wallace; Christopher E Dandoy; Kelly Lake; Alexandra Duell; Bridget Litts; Alix E Seif; Timothy Olson; Nancy Bunin; Stella M Davies Journal: Clin Infect Dis Date: 2020-12-15 Impact factor: 9.079
Authors: Lisa Peterson; Helmut Ostermann; Michael Fiegl; Johanna Tischer; Gundula Jaeger; Christina T Rieger Journal: Infection Date: 2016-01-20 Impact factor: 3.553